CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia

Overview of attention for article published in Investigational New Drugs, September 2018

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 1,183 followers.

CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia. https://t.co/mVdHeZ0P2S

#Researcharticle #OralCDK9ihibitor @UniversitySA CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia https://t.co/tB3ANcHFED

RT @CancerPapers: CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia. https://t.co/EXI7JP…

CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia. https://t.co/EXI7JPhOYt https://t.co/1cM0KW0DxY